Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia

Influence on Cure Rates and Risk of Second Cancer

Mette Levinsen, Elisabeth Orskov Rotevatn, Susanne Rosthoj, Jacob Nersting, Jonas Abrahamsson, Malin Lindqvist Appell, Stein Bergan, Anne-Grete Bechensteen, Arja Harila-Saari, Mats Heyman, Olafur Gisli Jonsson, Jakob Bernhard Cohn Maxild, Mikko Niemi, Stefan Soderhall, Kjeld Schmiegelow, Nordic Soc Paediat Haematology

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

Alkuperäiskielienglanti
LehtiPediatric Blood & Cancer
Vuosikerta61
Numero5
Sivut797-802
Sivumäärä6
ISSN1545-5009
DOI - pysyväislinkit
TilaJulkaistu - toukokuuta 2014
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

  • 3122 Syöpätaudit
  • 3123 Naisten- ja lastentaudit

Lainaa tätä

Levinsen, M., Rotevatn, E. O., Rosthoj, S., Nersting, J., Abrahamsson, J., Appell, M. L., ... Nordic Soc Paediat Haematology (2014). Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia: Influence on Cure Rates and Risk of Second Cancer. Pediatric Blood & Cancer, 61(5), 797-802. https://doi.org/10.1002/pbc.24921
Levinsen, Mette ; Rotevatn, Elisabeth Orskov ; Rosthoj, Susanne ; Nersting, Jacob ; Abrahamsson, Jonas ; Appell, Malin Lindqvist ; Bergan, Stein ; Bechensteen, Anne-Grete ; Harila-Saari, Arja ; Heyman, Mats ; Jonsson, Olafur Gisli ; Maxild, Jakob Bernhard Cohn ; Niemi, Mikko ; Soderhall, Stefan ; Schmiegelow, Kjeld ; Nordic Soc Paediat Haematology. / Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia : Influence on Cure Rates and Risk of Second Cancer. Julkaisussa: Pediatric Blood & Cancer. 2014 ; Vuosikerta 61, Nro 5. Sivut 797-802.
@article{1c03cecdc40e45759b82d390947e5cf6,
title = "Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia: Influence on Cure Rates and Risk of Second Cancer",
keywords = "ALL, late effects of cancer treatment, outcomes research, therapy, IMPLEMENTATION CONSORTIUM GUIDELINES, MAINTENANCE CHEMOTHERAPY, METHYLTRANSFERASE GENOTYPE, MALIGNANT NEOPLASMS, NORDIC COUNTRIES, NOPHO ALL-92, CHILDREN, RELAPSE, MODELS, 3122 Cancers, 3123 Gynaecology and paediatrics",
author = "Mette Levinsen and Rotevatn, {Elisabeth Orskov} and Susanne Rosthoj and Jacob Nersting and Jonas Abrahamsson and Appell, {Malin Lindqvist} and Stein Bergan and Anne-Grete Bechensteen and Arja Harila-Saari and Mats Heyman and Jonsson, {Olafur Gisli} and Maxild, {Jakob Bernhard Cohn} and Mikko Niemi and Stefan Soderhall and Kjeld Schmiegelow and {Nordic Soc Paediat Haematology}",
year = "2014",
month = "5",
doi = "10.1002/pbc.24921",
language = "English",
volume = "61",
pages = "797--802",
journal = "Pediatric Blood & Cancer",
issn = "1545-5009",
publisher = "Wiley",
number = "5",

}

Levinsen, M, Rotevatn, EO, Rosthoj, S, Nersting, J, Abrahamsson, J, Appell, ML, Bergan, S, Bechensteen, A-G, Harila-Saari, A, Heyman, M, Jonsson, OG, Maxild, JBC, Niemi, M, Soderhall, S, Schmiegelow, K & Nordic Soc Paediat Haematology 2014, 'Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia: Influence on Cure Rates and Risk of Second Cancer', Pediatric Blood & Cancer, Vuosikerta 61, Nro 5, Sivut 797-802. https://doi.org/10.1002/pbc.24921

Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia : Influence on Cure Rates and Risk of Second Cancer. / Levinsen, Mette; Rotevatn, Elisabeth Orskov; Rosthoj, Susanne; Nersting, Jacob; Abrahamsson, Jonas; Appell, Malin Lindqvist; Bergan, Stein; Bechensteen, Anne-Grete; Harila-Saari, Arja; Heyman, Mats; Jonsson, Olafur Gisli; Maxild, Jakob Bernhard Cohn; Niemi, Mikko; Soderhall, Stefan; Schmiegelow, Kjeld; Nordic Soc Paediat Haematology.

julkaisussa: Pediatric Blood & Cancer, Vuosikerta 61, Nro 5, 05.2014, s. 797-802.

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

TY - JOUR

T1 - Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia

T2 - Influence on Cure Rates and Risk of Second Cancer

AU - Levinsen, Mette

AU - Rotevatn, Elisabeth Orskov

AU - Rosthoj, Susanne

AU - Nersting, Jacob

AU - Abrahamsson, Jonas

AU - Appell, Malin Lindqvist

AU - Bergan, Stein

AU - Bechensteen, Anne-Grete

AU - Harila-Saari, Arja

AU - Heyman, Mats

AU - Jonsson, Olafur Gisli

AU - Maxild, Jakob Bernhard Cohn

AU - Niemi, Mikko

AU - Soderhall, Stefan

AU - Schmiegelow, Kjeld

AU - Nordic Soc Paediat Haematology

PY - 2014/5

Y1 - 2014/5

KW - ALL

KW - late effects of cancer treatment

KW - outcomes research

KW - therapy

KW - IMPLEMENTATION CONSORTIUM GUIDELINES

KW - MAINTENANCE CHEMOTHERAPY

KW - METHYLTRANSFERASE GENOTYPE

KW - MALIGNANT NEOPLASMS

KW - NORDIC COUNTRIES

KW - NOPHO ALL-92

KW - CHILDREN

KW - RELAPSE

KW - MODELS

KW - 3122 Cancers

KW - 3123 Gynaecology and paediatrics

U2 - 10.1002/pbc.24921

DO - 10.1002/pbc.24921

M3 - Article

VL - 61

SP - 797

EP - 802

JO - Pediatric Blood & Cancer

JF - Pediatric Blood & Cancer

SN - 1545-5009

IS - 5

ER -